GYG1P1

Across TCGA pan-cancer cohorts, GYG1P1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated GYG1P1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher GYG1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GYG1P1 expression acts as an unfavorable survival marker, although some lineages such as PRAD and COAD show a favorable association.

KIRC, STAD, and MESO are the cancer types where GYG1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	III,IV	0.298	0.511	.001	66	view →
STAD	DFS	Median	IV	0.157	0.566	.003	27	view →
MESO	DFS	Tertile	II,III,IV	0.170	0.606	.001	27	view →
KIRP	OS	Tertile	All	0.356	0.782	.001	21	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
THCA	DFS	Tertile	IV	0.477	0.852	.033	18	view →
LUSC	OS	Quartile	II,III,IV	0.545	0.852	.004	16	view →
UVM	DFS	Quartile	III,IV	0.338	0.768	.029	14	view →
PRAD	DFS	Quartile	All	0.946	0.864	.016	14	view →
THYM	OS	Tertile	All	0.624	0.892	.017	12	view →
KICH	DFS	Tertile	IV	0.317	0.923	.038	9	view →
COAD	OS	Quartile	All	0.936	0.843	.004	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

GYG1P1–KIRC (DFS)

Open the KIRC breakdown →